MX4813E - Procedimiento para preparar analogos de prostaglandinas - Google Patents

Procedimiento para preparar analogos de prostaglandinas

Info

Publication number
MX4813E
MX4813E MX77100668U MX10066877U MX4813E MX 4813 E MX4813 E MX 4813E MX 77100668 U MX77100668 U MX 77100668U MX 10066877 U MX10066877 U MX 10066877U MX 4813 E MX4813 E MX 4813E
Authority
MX
Mexico
Prior art keywords
prostaglandinas
procedure
preparing analogs
analogs
preparing
Prior art date
Application number
MX77100668U
Other languages
English (en)
Spanish (es)
Inventor
Norman Allan Nelson
Udo Friedrich Axen
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of MX4813E publication Critical patent/MX4813E/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/10—Mercury compounds

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX77100668U 1976-06-01 1977-04-10 Procedimiento para preparar analogos de prostaglandinas MX4813E (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US69140076A 1976-06-01 1976-06-01
US69139976A 1976-06-01 1976-06-01
US78814777A 1977-04-19 1977-04-19
US78814677A 1977-04-19 1977-04-19

Publications (1)

Publication Number Publication Date
MX4813E true MX4813E (es) 1982-10-19

Family

ID=27505431

Family Applications (1)

Application Number Title Priority Date Filing Date
MX77100668U MX4813E (es) 1976-06-01 1977-04-10 Procedimiento para preparar analogos de prostaglandinas

Country Status (13)

Country Link
JP (1) JPS5936912B2 (fr)
AU (1) AU508891B2 (fr)
BE (1) BE855224A (fr)
CA (1) CA1196632A (fr)
CH (1) CH640847A5 (fr)
DE (1) DE2724555A1 (fr)
FR (1) FR2353543B1 (fr)
GB (1) GB1554048A (fr)
IE (1) IE45604B1 (fr)
IL (1) IL52099A (fr)
MX (1) MX4813E (fr)
NL (1) NL7705991A (fr)
SE (3) SE436744B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL51189A (en) * 1976-02-04 1985-08-30 Upjohn Co Prostaglandin analogs
FI71138C (fi) 1976-12-31 1986-11-24 Erba Farmitalia Foerfarande foer framstaellning av terapeutiskt aktiva bisykliska prostaglandiner
AU524786B2 (en) * 1977-03-07 1982-10-07 The Upjohn Company Prostacyclins
DE2743283A1 (de) * 1977-09-27 1979-04-05 Hoechst Ag Neue prostacyclin-analoga
DE2811950A1 (de) * 1978-03-18 1979-12-13 Hoechst Ag Neue analoga von prostacyclin
US4237060A (en) 1979-03-23 1980-12-02 Hoffmann-La Roche Inc. Prostacyclin analogs
DE60023144T2 (de) 1999-08-05 2006-07-06 Teijin Ltd. Mittel zur besserung der neuropathie, die als wirkstoff stickstoffhaltige verbindungen enthalten

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1079025B (it) * 1976-05-11 1985-05-08 Wellcome Found Perfezionamento nella preparazione di eteri

Also Published As

Publication number Publication date
FR2353543A1 (fr) 1977-12-30
GB1554048A (en) 1979-10-17
CA1196632A (fr) 1985-11-12
SE8201649L (sv) 1982-03-16
IL52099A0 (en) 1977-07-31
SE7811142L (sv) 1978-11-28
BE855224A (fr) 1977-11-30
NL7705991A (nl) 1977-12-05
SE436744B (sv) 1985-01-21
JPS52156854A (en) 1977-12-27
IE45604B1 (en) 1982-10-06
JPS5936912B2 (ja) 1984-09-06
SE432101B (sv) 1984-03-19
IL52099A (en) 1985-03-31
SE7706245L (sv) 1977-12-16
AU508891B2 (en) 1980-04-03
FR2353543B1 (fr) 1986-02-21
CH640847A5 (en) 1984-01-31
AU2508677A (en) 1978-11-16
DE2724555A1 (de) 1977-12-15
IE45604L (en) 1977-12-01

Similar Documents

Publication Publication Date Title
MX4811E (es) Procedimiento para preparar derivados de prostaglandina
AR222007A1 (es) Procedimiento para la preparacion de nuevos hentriacontapeptidos
AR215930A1 (es) Procedimiento para la preparacion de compuestos 2-fenil-3-benzoil-benzotiofeno
MX4089E (es) Procedimiento mejorado para la preparacion de n-fosfonometilglicina
MX3654E (es) Procedimiento para preparar compuestos de sulfonilbencimidazol
MX3972E (es) Procedimiento para preparar compuestos de 2-aroil-3-fenilbenzotiofeno
MX3737E (es) Procedimiento para preparar compuestos de rifamacina
AR220683A1 (es) Procedimiento para la preparacion de m-fenoxibenzaldehido
MX146421A (es) Procedimiento mejorado para la preparacion de confuesto di (bis (tri-alcoxisiloxi) alquilsiloxi) alcanos
AR215875A1 (es) Procedimiento para la prepararacion de meta-fenoxi-benzaldehido
AR221081A1 (es) Procedimiento para preparar derivados de fenoximetil-piperidino-propoxi-indol
AR210349A1 (es) Procedimiento para la preparacion de 6-coloro-2(piperacinil)piracina
MX147874A (es) Procedimiento para preparar compuestos 2-fenoxi-5-trifluorometilpiridina
MX4664E (es) Procedimiento mejorado para la preparacion de derivados de n-fosfonometilglicina
MX4940E (es) Procedimiento para la preparacion de analogos de prosta glandina
MX4594E (es) Procedimiento para preparar combuestos de 3-halometilcefem
AR213430A1 (es) Procedimiento para la preparacion de nuevas n-cianoalquil-p-halofenoxi-isobutiramidas
AR215634A1 (es) Procedimiento para la preparacion de derivados de psoraleno
MX143639A (es) Procedimiento para la preparacion de compuestos disazoicos tetrarreactivos
AR213175A1 (es) Procedimiento para preparar s-derivados de 3-amino-4-imino-rifamicina
MX4750E (es) Procedimiento para la preparacion de gamma-pironas
AR230642A1 (es) Procedimiento para la preparacion de un indoledihidroindolcarboxamida dimerica
MX3513E (es) Procedimiento para preparar compuestos de formamidosulfenilanina
AR212328A1 (es) Procedimiento para preparar analogos de 16-alcoxi y 16-fenoxi prostaglandina
MX4291E (es) Procedimiento para preparar compuestos de aroil-fenilnaftaleno